Releasing psychiatry from the constraints of categorical diagnosis

Australasian Psychiatry

Volumn 15, Issue 1, 2007, Pages 3-5

  Mellsop, Graham ^a   Menkes, David ^a   El Badri, Selim ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Categories; Classification; Dimensions; Psychiatry

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM SALT; MOOD STABILIZER; NEUROLEPTIC AGENT;

AGE DISTRIBUTION; ARTICLE; BEHAVIOR THERAPY; CLINICAL DECISION MAKING; CLINICAL RESEARCH; COGNITIVE THERAPY; DAILY LIFE ACTIVITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG SENSITIVITY; ELECTROCONVULSIVE THERAPY; ETHNICITY; FAMILY COUNSELING; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LEGAL ASPECT; MENTAL DISEASE; MENTAL HEALTH CARE; OBSESSIVE COMPULSIVE DISORDER; PERSONALITY; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RELAPSE; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; TREATMENT INDICATION; TREATMENT PLANNING; VALIDITY;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS; PSYCHIATRY;

EID: 34248152766     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560601083134     Document Type: Article

References (30)

1. Mayer-Gross, W., Slater, E. and Roth, M. (1960) Clinical Psychiatry, Bailliere, Tindall and Cassell, London
2. Pichot, P. (1986) Nosological developments in European psychiatry and psychopharmacology. Pharmacopsychiatry, 19, pp. 23-25.
3. Robins, E. and Guze, SB. (1970) Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. American Journal of Psychiatry, 126, pp. 983-986.
4. National Collaborating Centre for Mental Health Schizophrenia (2003) Full National Clinical Guideline on Core Interventions in Primary and Secondary Care, Gaskell and the British Psychological Society, London
5. National Collaborating Centre for Mental Health Depression (2004) Full National Clinical Guideline on the Management of Depression in Primary and Secondary Care, Gaskell and the British Psychological Society, London
6. Frangou, S. (2005) Advances in Psychiatric Treatment, 11, pp. 28-37.
7. Goodman, WK. (2002) Pharmacotherapy of OCD. Textbook of Anxiety Disorders, American Psychiatric Publishing, Washington
8. Mezzich, JE, Fabrega, H. and Coffman, GA. (1987) Multiaxial characterisation of depressive patients. Journal of Nervous and Mental Disease, 175, pp. 339-346.
9. Tasman, A. (2002) Lost in the DSM-IV checklist: Empathy, meaning and the doctor-patient relationship. Academic Psychiatry, 26, pp. 38-44.
10. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, World Health Organization, Geneva
11. American Psychiatric Association (2000) Diagnostic and Statistical Manual, Fourth Edition, American Psychiatric Association, Washington
12. Healy, D. (2002) The Creation of Psychopharmacology, Harvard University Press, Cambridge
13. Lexchin, J., Bero, LA, Djulbegovie, B. and Clark, O. (2003) Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. British Medical Journal, 326, pp. 1167-1170.
14. Verhoeven, WMA and Tuinier, S. (2001) Two steps forward, one step back; paradigmatic changes in psychiatry. Journal of Neural Transmission, 108, pp. 617-627.
15. Lobo, A. (1989) On multiaxial psychiatric diagnosis for general medical patients. British Journal of Psychiatry, 154, pp. 38-41.
16. Mezzich, JE. (2005) Values and comprehensive diagnosis. World Psychiatry, 4, pp. 91-92.
17. Phelan, M. and McCrone, P. (1995) Effectiveness of diagnosis related groups in predicting psychiatric resource utilisation in the UK. Psychiatric Services, 46, pp. 547-549.
18. Eager, K., Gaines, P. and Burgess, P. (2004) Developing a New Zealand casemix classification for mental health services. World Psychiatry, 3, pp. 172-177.
19. MaGPIe Research Group (2003) The nature and prevalence of psychological problems in New Zealand primary healthcare. New Zealand Medical Journal, 116, p. 1171.
20. Ashcraft, MLF, Fries, BE and Nerrenz, DR (1989) A psychiatric patient classification system: An alternative to DRGs. Medical Care, 27, pp. 543-557.
21. Furtado, VA and Srihari, V. (2005) Atypical antipsychotics for people with both schizophrenia and depression (protocol).
22. Maricle, R., Leung, P. and Bloom, JD. (1987) The use of DSM-III axis III in recording physical illness in psychiatric patients. American Journal of Psychiatry, 144, pp. 1484-1486.
23. Skodol, AE. (1991) Axis IV: A reliable and valid measure of psychosocial stressors?. Comprehensive Psychiatry, 32, pp. 503-515.
24. Rey, JM, Stewart, GW, Plapp, JM, Bashir, M. and Richards, I. (1988) DSM-III axis IV revisited. American Journal of Psychiatry, 145, pp. 286-292.
25. Saavedra, JE, Mezzich, JE, Salloum, IM and Kirisci, L. (1997) Predictive validity of the physical disorders axis of the DSM multiaxial diagnostic system. Journal of Nervous and Mental Diseases, 189, pp. 435-441.
26. Jablensky, A. (1999) The nature of psychiatric classification: Issues beyond ICD-10 and DSM-IV. Australia and New Zealand Journal of Psychiatry, 33, pp. 137-144.
27. Mellsop, GW and El-Badri, SM (2006) Developing classification in psychiatry: Implications of 50 years of progress in psychopharmacologic therapeutics. European Pharmacotherapy, pp. 83-86.
28. D'Ercole, A., Skodol, AE, Struening, E., Curtis, J. and Millman, J. (1991) Diagnosis of physical illness in psychiatric patients using axis iii and a standardized medical history. Hospital and Community Psychiatry, 42, pp. 395-400.
29. Widiger, T. (2005) Five factor model of personality disorder: Integrating science and practice. Journal of Research in Personality, 39, pp. 67-83.
30. Baca-Garcia, E., Perez-Rodriquez, MM and Basurte-Villamor, I. (2006) Diagnositc stability of disorders in clinical practice: A prospective cohort study. British Journal of Psychiatry